Speakers:
- Brian Kingwell, Partner, Gowling WLG
- Isabelle Riedl, Senior Supervisor, Intellectual Property, Medicago
- Sonia Ziesche, Principal, Patent Agent, Gowling WLG
Stay up-to-date with all of the life science events taking place in Vancouver with the Science in Vancouver events calendar! From academia to industry and biotech to pharma, our events calendar is your complete source for life science conferences, symposiums, networking, and workshops in Vancouver.
If you’re interested in promoting a life science event in our calendar, please use our event submission form.
Drug development in Canada is a long and complex process, and the market is competitive. At the heart of drug development is intellectual property (IP). Life sciences companies who develop an IP strategy at the outset of a new project have a competitive advantage by creating value, generating revenue, and obtaining market intelligence. Without a strategy, companies risk losing IP assets, missing out on investment opportunities, and being exposed to competition.
On Wednesday, October 20, join a panel of industry insiders who will discuss the key IP opportunities and strategies related to drug development in Canada. The panel will touch on everything from identifying intellectual property during R&D to the importance of freedom to operate analysis, international filing strategies and portfolio management, and of course, the unique industry challenges brought to light due to the COVID-19 pandemic.
Speakers:
Date: Wednesday, October 20, 2021
Time: 10:00AM – 11:00AM PT
Platform: Zoom
Tickets: Free for LSBC members & $25 for LSBC non-members